Large genome-wide association study on nonalcoholic fatty liver disease

By | October 25, 2022
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD).